The clinical standard of care for criticallysized cutaneous defects has remained meshed split-thickness skin grafts (STSGs), as seen in a variety of surgical, chronic, and burn wound reconstruction efforts. STSGs however, due to the intrinsic limited depth of harvest, remain unable to obtain the potent stem cell population which exists deeper within the dermis and therefore fail to regenerate cutaneous appendages, inter-follicular dermis as well as full-thickness skin. While there remain a variety of commercial skin substitutes which assist in healing cutaneous wounds, none have claimed to regenerate full thickness skin or appendages, until recently. SkinTE™ (PolarityTE, Salt Lake City, Utah), an autologous homologous human tissue product, has regenerated full-thickness skin in preclinical studies, and is further examined here in clinical application.
RESULTS:
Full-thickness regeneration was noted beginning one week postoperatively, with rapid neo-dermal expansion, epithelialization and pigmentation occurring from discrete foci. Melanin deposition occurred throughout the wound with early return of pigmentation across the treated surface area. Additionally, contraction of the wound margin and peri-wound bed were minimal when comparing sequential images throughout the postoperative period. Macroscopic imaging of the interfaced margin of the wound (native tissue to SkinTE™) showed regions of complete scar resolution with minimal observed scar line.
CONCLUSION:
Utilization of SkinTE appears to be a viable reconstructive technique for patients requiring fullthickness skin regeneration and/or replacement of the current clinical standard of care, a STSG. In this case, where a previously placed STSG with advanced scarring and keloid formation was resurfaced, the product appears to have regenerated full-thickness, pigmented skin with limited contraction.
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Presenter: Jayant Agarwal, MD Co-Authors: Erik Kubiak, MD; Jeremy Gililland, MD; Bart Gillespie, DPT; James Peter Beck, MD; Sarina Sinclair, PhD Affiliation: University of Utah, Salt Lake City, UT Skin breakdown, infections, discomfort from scarring or heterotopic bone, and frequent adjustments due to residual limb volume changes limit the success of socket suspension technology for transfemoral (TF) amputees. These challenges prohibit many amputees from comfortably wearing their prosthesis or from being able to perform many activities. European and Australian programs have been implanting percutaneous osseointegrated (OI) devices in amputees for over two decades as an alternative means of artificial limb suspension that maintain a secure connection without the complications associated with socket technology. Reported risks of OI implants include mechanical failure, aseptic loosening and infection rates of 30-55%.
1 No OI device has received full Premarket Approval by the FDA for clinical use within the United States. For the past ten years our research team has performed preclinical tests to design a new OI device, the Percutaneous Osseointegrated Prosthesis (POP), aiming to limit infection and provide a mechanically stable implant that allows for rapid return to ambulation. Traditional TE port localization utilizes a small dangle magnet to help determine the needle entry point for expansion. Tissue thickness, fluid accumulation, or displacement of the TE can make precise port localization more difficult. More accurate localization of the magnetic fill port minimizes the risk of inadvertent puncture during access. We have developed a novel device, called PortFindr, to more accurately localize the subcutaneous expander fill port.
METHODS:
A single-blinded experiment was conducted to determine the accuracy of a traditional dangle magnet in comparison PortFindr. A Sientra single port DermaspanTM tissue expander filled to 300ml was placed beneath three different foam skin equivalents (A 11mm, B 21mm, and C 32mm) by the non-blinded researcher. The blinded researcher then used either the PortFindr or standard dangle magnet to determine the location of the port and insert a needle into the expander port. The distance of the needle to the center of the port was measured (mm) using an electronic caliper and the quadrant the of needle insertion was noted. Thirty trials were completed for each parameter tested. Additionally, the effect of distance on the force of magnetic attraction between the dangle magnet and the TE port was conducted using a tension force gauge.
RESULTS:
At each tissue thickness, the mean distance from center was significantly less in trials using the Portfindr compared to trials using the magnet (p<0.05). The mean distance from center using the Portfinder at thickness A, B, and C was 1.84mm, 2.39mm, and 5.48mm, respectively. The dangle magnet average distance from center was 3.03mm, 3.71mm, and 6.33mm. Standard deviation values were lower in trials using the Portfindr compared
